Filters Alter the Performance of Noninvasive Ventilators.


Journal

Respiratory care
ISSN: 1943-3654
Titre abrégé: Respir Care
Pays: United States
ID NLM: 7510357

Informations de publication

Date de publication:
07 2022
Historique:
pubmed: 25 5 2022
medline: 23 6 2022
entrez: 24 5 2022
Statut: ppublish

Résumé

Noninvasive ventilation is recommended in hypercapnic respiratory failure secondary to ventilatory failure. Noninvasive ventilation may contribute to aerosol dispersion, which may increase the risk of transmission of COVID 2019. The addition of filters to the ventilator circuit has been recommended to reduce this risk. The aim of this benchtop study was to investigate the impact of adding filters to a ventilator circuit. In this benchtop study, a breathing simulator was used with 4 commonly used ventilators. Ventilators were set to approximate the typical settings that are used for patients on long-term noninvasive ventilation. Ventilator performance was then evaluated with 3 circuit configurations in place: circuit A: no filter in situ; circuit B: 1 filter at the simulator end of the circuit; and circuit C: 1 filter at the simulator end of the circuit and a second filter at the ventilator end of the circuit. Ventilator variables were impacted by the addition of filters. Measurements of peak pressure ( This study demonstrated that ventilator settings established with filters in situ are not applicable if the ventilator is used without the filters. This is an important clinical consideration for patients who are hospitalized and require noninvasive ventilation in the COVID 2019 era.

Sections du résumé

BACKGROUND
Noninvasive ventilation is recommended in hypercapnic respiratory failure secondary to ventilatory failure. Noninvasive ventilation may contribute to aerosol dispersion, which may increase the risk of transmission of COVID 2019. The addition of filters to the ventilator circuit has been recommended to reduce this risk. The aim of this benchtop study was to investigate the impact of adding filters to a ventilator circuit.
METHODS
In this benchtop study, a breathing simulator was used with 4 commonly used ventilators. Ventilators were set to approximate the typical settings that are used for patients on long-term noninvasive ventilation. Ventilator performance was then evaluated with 3 circuit configurations in place: circuit A: no filter in situ; circuit B: 1 filter at the simulator end of the circuit; and circuit C: 1 filter at the simulator end of the circuit and a second filter at the ventilator end of the circuit.
RESULTS
Ventilator variables were impacted by the addition of filters. Measurements of peak pressure (
CONCLUSIONS
This study demonstrated that ventilator settings established with filters in situ are not applicable if the ventilator is used without the filters. This is an important clinical consideration for patients who are hospitalized and require noninvasive ventilation in the COVID 2019 era.

Identifiants

pubmed: 35610028
pii: respcare.09365
doi: 10.4187/respcare.09365
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

795-800

Informations de copyright

Copyright © 2022 by Daedalus Enterprises.

Déclaration de conflit d'intérêts

Dr Howard reports provision of equipment from ResMed and Philips Respironics. The other authors have disclosed no conflicts of interest.

Auteurs

Julie Tolson (J)

Department of Respiratory and Sleep Medicine, Austin Health, Heidelberg, Victoria, Australia. julie.tolson@austin.org.au.
Institute for Breathing and Sleep, Heidelberg, Victoria, Australia.
The University of Melbourne, Melbourne, Victoria, Australia.

Rodney Hone (R)

Department of Respiratory and Sleep Medicine, Austin Health, Heidelberg, Victoria, Australia.
Institute for Breathing and Sleep, Heidelberg, Victoria, Australia.

Christian Bandiera (C)

Swinburne University of Technology, Hawthorn, Victoria, Australia.

Linda Rautela (L)

Department of Respiratory and Sleep Medicine, Austin Health, Heidelberg, Victoria, Australia.
Institute for Breathing and Sleep, Heidelberg, Victoria, Australia.

Thomas J Churchward (TJ)

Department of Respiratory and Sleep Medicine, Austin Health, Heidelberg, Victoria, Australia.
Institute for Breathing and Sleep, Heidelberg, Victoria, Australia.

Anna Ridgers (A)

Department of Respiratory and Sleep Medicine, Austin Health, Heidelberg, Victoria, Australia.
Institute for Breathing and Sleep, Heidelberg, Victoria, Australia.
The University of Melbourne, Melbourne, Victoria, Australia.

Mark E Howard (ME)

Department of Respiratory and Sleep Medicine, Austin Health, Heidelberg, Victoria, Australia.
Institute for Breathing and Sleep, Heidelberg, Victoria, Australia.

Christopher J Worsnop (CJ)

Department of Respiratory and Sleep Medicine, Austin Health, Heidelberg, Victoria, Australia.
Institute for Breathing and Sleep, Heidelberg, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH